International Journal of Cell Cloning, Vol 7, 360-372, Copyright © 1989 by AlphaMed Press

ORIGINAL ARTICLES

Use of gel-well culture chambers as a liquid culture system to measure responses of hematopoietic colony-forming cells to growth factors

GN Schwartz
Transplantation Laboratory, American Red Cross, Rockville, Maryland 20855.

This report presents the results of an investigation in which Gel-Well culture chambers were evaluated for their utility as a liquid culture assay system to measure the responses of hematopoietic colony-forming cells (CFC) to recombinant and cell-derived growth factors. Gel-Wells, designed for anchorage-independent cell growth and diffusion of media components, permitted the weekly replacement of media and growth factors without removing cells from the culture chambers. In these studies, changes in cellularity and CFC content in Gel-Well cultures of human umbilical cord blood cells induced by recombinant interleukin 3 (rIL-3) were quantified. After one week in culture without rIL-3, the number of erythroid burst-forming units (BFU-e) had decreased to 25 +/- 38% of pre-values. In contrast, addition of rIL-3 induced an increase in the number of BFU-e to 390 +/- 135% of pre-values. By three weeks with rIL-3, the number of granulocyte-macrophage colony-forming units (CFU-gm) had increased to 292 +/- 58% of pre-values. Also, the presence of a bone marrow stromal cell layer under the Gel-Well helped to maintain the survival of CFC in liquid culture. These studies demonstrated that Gel-Well culture chambers provide a useful liquid culture system for studying the responses of CFC to growth factors.

This article has been cited by other articles:

				G. N. Schwartz, U. Kammula, M. K. Warren, M. K. Park, X.-Y. Yan, F. M. Marincola, and R. E. Gress Thrombopoietin and Chemokine mRNA Expression in Patient Post-Chemotherapy and In Vitro Cytokine-Treated Marrow Stromal Cell Layers Stem Cells, September 1, 2000; 18(5): 331 - 342. [Abstract] [Full Text]

				G. K. Koski, G. N. Schwartz, D. E. Weng, R. E. Gress, F. H.C. Engels, M. Tsokos, B. J. Czerniecki, and P. A. Cohen Calcium Ionophore-Treated Myeloid Cells Acquire Many Dendritic Cell Characteristics Independent of Prior Differentiation State, Transformation Status, or Sensitivity to Biologic Agents Blood, August 15, 1999; 94(4): 1359 - 1371. [Abstract] [Full Text] [PDF]

				G. K. Koski, G. N. Schwartz, D. E. Weng, B. J. Czerniecki, C. Carter, R. E. Gress, and P. A. Cohen Calcium Mobilization in Human Myeloid Cells Results in Acquisition of Individual Dendritic Cell-Like Characteristics Through Discrete Signaling Pathways J. Immunol., July 1, 1999; 163(1): 82 - 92. [Abstract] [Full Text] [PDF]

				G. Schwartz, M. Warren, K Sakano, J. Szabo, S. Kessler, A Pashapour, R. Gress, and J. Perdue Comparative effects of insulin-like growth factor II (IGF-II) and IGF- II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis Stem Cells, May 1, 1996; 14(3): 337 - 350. [Abstract]